Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
HUTCHMED (China) Limited (NASDAQ: HCM)
HCM Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
7.90%
Analyst Rating:
SELL
Analyst Forecast (1yr):
-39.20%
HCM Stock Analysis
HCM
PE Ratio:
4.4
HCM
PEG Ratio:
Not Available
HCM
Forward EPS Growth (12 month):
0.00%
HCM
PS Ratio:
3.6
HCM
PSG Ratio:
Not Available
HCM
Forward Revenue Growth (12 month):
0.00%
HCM Articles
No data was found